1. "Nystatin". Issue 4974 (5th May 1956) Authors: Chesney, J. Journal: BMJ Issue: Volume 1:Issue 4974(1956) Page Start: 1044 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 115 Regulation of twist and slug by PFKFB2. (September 2015) Authors: Yalcin, A.; Ozcan, S.C.; Guzel, S.; Chesney, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 293 INDUCIBLE 6-PHOSPHOFRUCTO-2-KINASE IS AN ESSENTIAL DOWNSTREAM EFFECTOR OF THE ONCOGENE RAS. (1st January 2005) Authors: Telang, S.; Yalcin, A.; Clem, A.; Chesney, J. Journal: Journal of investigative medicine Issue: Volume 53:Number 1(2005) Page Start: S305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 294 PHARMACOPHORE TARGETING OF THE FRUCTOSE-6-PHOSPHATE BINDING SITE OF IPFK-2 SUPPRESSES TUMOR GROWTH. (1st January 2005) Authors: Chesney, J.; Clem, A.; Meier, J.; Swanson, P.; Yalcin, A.; Arumugam, S.; Lane, A.; Trent, J.; Telang, S. Journal: Journal of investigative medicine Issue: Volume 53:Number 1(2005) Page Start: S305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 3334 Durable complete responses (CR) in patients (pts) with stage IIIB-IV melanoma treated with talimogene laherparepvec (T-VEC) in OPTiM. (September 2015) Authors: Andtbacka, R.H.I.; Kaufman, H.; Collichio, F.; Amatruda, T.; Nemunaitis, J.; Chesney, J.; Puzanov, I.; Harrington, K.; Zhang, Y.; Chen, L.; Shilkrut, M.; Ross, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S676 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 35MO Number of IL-2 doses and clinical outcomes of tumor-infiltrating lymphocyte (TIL) cell therapy: Post hoc analysis of the C-144-01 trial of lifileucel in patients with advanced melanoma. (December 2022) Authors: Hassel, J.C.; Sarnaik, A.; Chesney, J.; Medina, T.; Hamid, O.; Thomas, S.; Wermke, M.; Domingo-Musibay, E.; Kirkwood, J.M.; Larkin, J.; Weber, J.S.; Arance Fernandez, A.M.; Rodriguez, J.F.; Thomas, I.; Corrie, P.G.; Gontcharova, V.; Wu, X.; Shi, W.; Kluger, H. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Hyaluronidase in Paraphimosis. Issue 4959 (21st January 1956) Authors: Chesney, J. Journal: BMJ Issue: Volume 1:Issue 4959(1956) Page Start: 170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Peripheral blood fibrocytes: novel fibroblast-like cells that present antigen and mediate tissue repair. (May 1997) Authors: Chesney, J.; Bucala, R. Journal: Biochemical Society transactions Issue: Volume 25:Number 2(1997) Page Start: 520 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Peyronie's Disease. Issue 5391 (2nd May 1964) Authors: Chesney, J. Journal: BMJ Issue: Volume 1:Issue 5391(1964) Page Start: 1182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The Use of Stilboestrol in the Treatment of Carcinoma of the Prostate. Issue 229 (December 1944) Authors: Chesney, J. Journal: Postgraduate medical journal Issue: Volume 20:Issue 229(1944) Page Start: 355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗